Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials. - Chatur, Safia; Vaduganathan, Muthiah; Fletcher, Robert A.; Perkovic, Vlado; Heerspink, Hiddo; Arnott, Clare; Pollock, Carol; Mahaffey, Kenneth W.; Neal, Bruce; Jardine, Meg; Solomon, Scott D.; Neuen, Brendon L. (European Journal of Heart Failure, 2025)